One groundbreaking instrument. 75 innovations to empower your work. Learn more about the NextSeq 2000 at Illumina Access. #illuminaaccess #genomics24 | Illumina, Inc.

Accurately identify SARS-CoV-2 variants with Illumina’s scalable genomic sequencing solutions. https://ilmnmkt.illumina.com/2016006721 | Illumina, Inc.

Secure funding, increase productivity and propel discoveries. Empower your research with next-generation sequencing. Learn more on NGS from our Benefits of NGS video and Introduction to NGS webinar: https://ilmnmkt.illumina.com/2016004777 | Illumina, Inc.

With greater capacity for ground breaking discoveries, simplified workflows, reduced sequencing costs, and advanced flexibility to support new and emerging applications, what will you discover? #ExperienceNextSeq2000 https://ilmnmkt.illumina.com/2016004037 | Illumina, Inc.

Our customers asked, and we listened. A lower throughput flow cell that was cost effective and faster to run on a NextSeq 1000 or 2000 instrument was requested and now, here it is. The new P1 flow cell has 100 million reads and 300 cycles, meaning reduced batching requirements, faster sequencing, cost effective and accurate data. | Illumina, Inc.

Evolutionary geneticist, Eske Willerslev, is decoding the genetic origins of mental health by sequencing DNA from 10,000-year-old bones & teeth to see if ancient DNA may hold the answers to today’s mental health issues. | Illumina, Inc.